Alexandria Real Estate Equities, Inc. (ARE) short interest & options flow

ARE JP Morgan downgrades to Underweight, sets $56 price target amid rising short interest and earnings headwinds.

ARE faces mounting pressure after JP Morgan analyst Anthony Paolone downgraded the healthcare REIT from Neutral to Underweight today with a $56 price target—below the current $51.86 close. Short interest has surged 17% over the past month to 4.79% of free float, while the stock trades 3% below last week. Insiders have net-sold $878K in stock over 90 days. Earnings forecasts show core earnings declining 28.3% in 2026 and 6.8% in 2027, pressuring the dividend narrative. Analyst consensus remains mixed: Evercore ISI maintains Outperform at $59, while BNP Paribas and Citizens rate it Underperform or Market Perform. Cost to borrow remains low at 0.53%, but availability of shares to short sits at 1,879% of short interest—ample supply for bears. Next earnings: October 19.